The ADD1/ADD2 Antibody (PACO06234) is a key tool for researchers studying the ADD1 and ADD2 proteins, which are essential components in the assembly of spectrin-actin network in red blood cells. This polyclonal antibody is produced in rabbits and exhibits high specificity and reactivity for human samples, making it suitable for a range of applications such as Western blotting and immunofluorescence.ADD1 and ADD2 are crucial for maintaining the structural integrity of red blood cells and mutations in these genes have been linked to various blood disorders, including hereditary elliptocytosis and hereditary spherocytosis.
By targeting these proteins with the PACO06234 antibody, researchers can gain valuable insights into the mechanisms underlying these conditions and potentially identify new therapeutic targets for treatment.
Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to calmodulin.
NCBI Summary:
Adducins are a family of cytoskeletal proteins encoded by three genes (alpha, beta, and gamma). Adducin acts as a heterodimer of the related alpha, beta, or gamma subunits. The protein encoded by this gene represents the alpha subunit. Alpha- and beta-adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. Adducin binds with high affinity to Ca(2+)/calmodulin and is a substrate for protein kinases A and C. [provided by RefSeq, Aug 2017]